Will Sorafenib Help?: Treatment-aware Reranking in Precision Medicine Search

3Citations
Citations of this article
6Readers
Mendeley users who have this article in their library.
Get full text

Abstract

High-quality evidence from the biomedical literature is crucial for decision making of oncologists who treat cancer patients. Search for evidence on a specific treatment for a patient is the challenge set by the precision medicine track of TREC in 2020. To address this challenge, we propose a two-step method to incorporate treatment into the query formulation and ranking. Training of such ranking function uses a zero-shot setup to incorporate the novel focus on treatments which did not exist in any of the previous TREC tracks. Our treatment-aware neural reranking approach, FAT, achieves state-of-the-art effectiveness for TREC Precision Medicine 2020. Our analysis indicates that the BERT-based rerankers automatically learn to score documents through identifying concepts relevant to precision medicine, similar to hand-crafted heuristics successful in the earlier studies.

Cite

CITATION STYLE

APA

Rybinski, M., & Karimi, S. (2021). Will Sorafenib Help?: Treatment-aware Reranking in Precision Medicine Search. In International Conference on Information and Knowledge Management, Proceedings (pp. 3403–3407). Association for Computing Machinery. https://doi.org/10.1145/3459637.3482220

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free